We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Shionogi Gets Untitled Letter After Refusing To Conduct Postmarketing Study
Shionogi Gets Untitled Letter After Refusing To Conduct Postmarketing Study
May 23, 2013
The FDA issued Shionogi an untitled letter for refusing to conduct a postmarketing study required as part of an NDA approval.